Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Canopy Growth ( (TSE:WEED) ) has provided an update.
Canopy Growth has launched its Tweed brand in the German medical cannabis market, introducing four new strains through a partnership with Portuguese cultivator Gro-Vida. This expansion, which includes the earlier introduction of the Glitter Bomb strain via Cansativa, aims to meet the increasing demand for high-THC genetics among German medical patients, enhancing Canopy Growth’s presence in the European market.
More about Canopy Growth
Canopy Growth Corporation is a world-leading cannabis company focused on improving lives through cannabis. Originating in Canada, the company operates in both adult-use and medical cannabis markets globally.
YTD Price Performance: -47.92%
Average Trading Volume: 7,155,429
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $254.1M
For detailed information about WEED stock, go to TipRanks’ Stock Analysis page.